AIG
AUPH icon

American International Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

American International Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-66,738
Closed -$334K – 248
2024
Q1 		$334K Sell
66,738
-573
-0.9% -$3.89K ﹤0.01% 1865
2023
Q4 		$605K Sell
67,311
-272
-0.4% -$2.24K ﹤0.01% 1559
2023
Q3 		$525K Buy
67,583
+2,403
+4% +$23.5K ﹤0.01% 1573
2023
Q2 		$631K Buy
65,180
+437
+0.7% +$4.54K ﹤0.01% 1507
2023
Q1 		$710K Buy
64,743
+1,288
+2% +$11.3K ﹤0.01% 1415
2022
Q4 		$274K Sell
63,455
-231
-0.4% -$1.34K ﹤0.01% 1958
2022
Q3 		$479K Buy
63,686
+900
+1% +$7.79K ﹤0.01% 1608
2022
Q2 		$631K Buy
+62,786
New +$702K ﹤0.01% 1463

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

American International Group's AUPH Position: Q2 2024 in Review

American International Group sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2024, closing a stake of 66,738 shares — an estimated $334K sold.

American International Group first reported a position in AUPH in Q2 2022 and held it in 8 quarters. The position peaked at $710K in Q1 2023. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2024.

  • American International Group reported no remaining Aurinia Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 66,738 Aurinia Pharmaceuticals shares in Q2 2024, an estimated $334K.
  • American International Group first reported a position in Aurinia Pharmaceuticals in Q2 2022 and held it in 8 quarters.
  • American International Group's Aurinia Pharmaceuticals position peaked at $710K in Q1 2023.
  • 171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.